ロード中...
The future of kinase inhibitors for DLBCL?
In this issue of Blood, Battistello et al present results exploring inhibition of signaling across key nodes in the B-cell receptor (BCR) signaling pathway for Bruton tyrosine kinase (BTK)-sensitive and BTK-insensitive diffuse large B-cell lymphoma (DLBCL).(1)
保存先:
| 出版年: | Blood |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5969385/ https://ncbi.nlm.nih.gov/pubmed/29794076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-04-841908 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|